Alembic Pharmaceuticals Receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg
Alembic Pharmaceuticals has secured the USFDA Final Approval for its Paroxetine Extended-Release Tablets USP, 12.5 mg. This product is…